26 phd-computer-science-"IMPRS-ML"-"IMPRS-ML"-"IMPRS-ML" positions at Ulster University
Sort by
Refine Your Search
-
on vaccine development. J Biomed Inform (2015) 53:405–414. 6. Shukla P, et al. Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82
-
computational approaches evidenced by good programming skills (preferable in Linux/Shell, Python and R) and knowledge in immunology, bioinformatics and statistics. However, students from more biology oriented
-
registered on a programme of research leading to the award of a doctoral degree on a full-time basis for more than one year (or part-time equivalent) are NOT eligible to apply for an award. *Part time PhD
-
the main means of informing conservation status. The advancement of technology, particularly camera traps, combined with their increased availability and reduced cost means that more reliable methods are
-
programme of research leading to the award of a doctoral degree on a full-time basis for more than one year (or part-time equivalent) are NOT eligible to apply for an award. *Part time PhD scholarships
-
. Combining computer vision with artificial intelligence will enable a PhD researcher to develop models that can reason, understand or learn like a human. The ability to identify defects, adapt to new and
-
level schools. 1 PhD opportunity is available for a candidate with a background in minority language sociolinguistics to assist with the delivery of the project's objectives and to conduct research
-
PhD project in collaboration with SONI Ltd and EirGrid plc, leading Transmission System Operators for Northern Ireland and Ireland. This industry-cooperative doctoral award focuses on developing a 2050
-
. (2024). AI Literacy: A Framework to Understand, Evaluate, and Use Emerging Technology. Su, J., & Yang, W. (2022). Artificial intelligence in early childhood education: A scoping review. Computers and
-
Development of an docetaxel-loaded implantable device for the localised treatment of prostate cancer
drug delivery technology designed for the sustained release of chemotherapy directly into cancer tissue thereby improving clinical performance. Prostate cancer is one of the most common types of cancer